Accsys Technologies PLC (LON:AXS) saw its shares drop sharply on Monday, falling 9.2% to 65.02 pence in early trading, as the company's profit guidance for the current fiscal year came in well below market expectations. The decline, which brought the stock to its lowest level in recent sessions, underscores investor concerns about the company's near-term earnings power.
The company, known for its acetylated wood products, guided adjusted EBITDA to a range of €21 million to €23 million for fiscal 2027. This compares unfavorably with the consensus estimate of €28.8 million, leaving a significant gap of around €6.8 million at the midpoint. The guidance reflects a slower start to the fiscal year, with group revenue for the first five months falling 6% to €56.9 million.
Sales volumes also took a hit, declining 11% on a group basis to 22,186 cubic metres, while total volume, including the Accoya USA joint venture, fell 8% to 28,953 cubic metres. The company noted that distributor destocking, particularly in North America, weighed on volumes, although the Accoya USA operation posted a 3% volume increase to 6,767 cubic metres.
The market reaction was swift and severe. By 08:27 BST, over 151,000 shares had changed hands, more than double the average daily volume of the past 20 sessions. The stock's day range was 63.08 pence to 66.40 pence, with the session's low marking a notable drop from Friday's close of 71.60 pence.
Management attributed the weaker performance to inventory adjustments across the supply chain, but expressed confidence that inventories are stabilizing and that September activity has improved. Despite this, the company still expects first-half revenue and volume to remain slightly below the prior year's levels.
The guidance implies only modest growth from fiscal 2026's adjusted EBITDA of €21.2 million, with the midpoint suggesting a 3.8% increase. This is a far cry from the double-digit growth investors might have hoped for, especially given CEO Jelena Arsic van Os's June statement that the company had been "transformed into a leaner and more effective organisation."
Analyst reactions have been mixed, with existing Buy ratings from Canaccord Genuity and Panmure Gordon offering price targets of 130 pence and 100 pence, respectively, implying significant upside from current levels. However, these targets predate Monday's warning and may be revised downward if the second-half recovery fails to materialize.
The key question for investors is whether the current weakness is a temporary blip or a sign of deeper issues. The company's ability to manage pricing and control costs will be critical in offsetting lower factory volumes. A renewed bout of destocking in North America or a slow recovery at its Arnhem facility could push EBITDA below the guided range, potentially straining the balance sheet.
Accsys is scheduled to report interim results on November 24, which will provide a clearer picture of first-half margins, joint-venture performance, and whether the claimed improvement in September orders is sustainable. Until then, the market is likely to remain cautious on the stock.
